Author

Helena Bode

Kinderkrebs-Zentrum Hamburg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

Alice Senta RybaiD· 1 shared Alicia BuckiD· 1 shared Amanda Salviano‐SilvaiD· 1 shared Annika K. WefersiD· 1 shared Benedikt WiestleriD· 1 shared Berend SnijderiD· 1 shared Cécile L. MaireiD· 1 shared Dana SilverbushiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alice Senta RybaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability

Richard Drexler, Robin Khatri, Thomas Sauvigny, Malte Mohme, Cécile L. Maire, Alice Senta Ryba, Yahya Zghaibeh, Lasse Dührsen, Amanda Salviano‐Silva, Katrin Lamszus, Manfred Westphal, Jens Gempt, Annika K. Wefers, Julia E. Neumann, Helena Bode, , Franz Lennard Ricklefs

The paper identifies an epigenetic neural signature in glioblastoma that correlates with poor prognosis and therapeutic vulnerability.

bioRxiv · Aug 4, 2023 · PreprintNeuroscience